Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Hisse Senetlerindeki Sıralama #40615
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Hisse Fiyatı
$0.13607016
Son senkronizasyon: 2024-09-10
Piyasa Değeri
$112.29K
Değişim (1 gün)
22.46%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret BiVictriX Therapeutics Plc (BVX)

Kategori

B piyasa değeri ile BVX fiyatı
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
BVX
$0.13607016
Piyasa Değeri BiVictriX Therapeutics Plc(BVX)
Piyasa Değeri: $112.29K
August 2026 itibarıyla BiVictriX Therapeutics Plc şirketinin piyasa değeri $112.29K. Bu, verilerimize göre BiVictriX Therapeutics Plc şirketini dünyanın en değerli 40615th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
BiVictriX Therapeutics Plc piyasa değeri geçmişi (2021 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında BVX
BVX’in Fiyatı B Varlığı B’nin Piyasa Değeri Sonuçlar
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$6,623,006 $112.29K
$5.466T +4,867,346,307.19%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,401,565 $112.29K
$4.458T +3,969,690,853.63%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,059,044 $112.29K
$4.175T +3,717,967,519.13%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$4,445,328 $112.29K
$3.669T +3,266,938,182.15%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$3,457,554 $112.29K
$2.853T +2,541,008,022.90%